Affinity cell extraction by acoustics

US11420136B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11420136-B2
Application numberUS-201715788784-A
CountryUS
Kind codeB2
Filing dateOct 19, 2017
Priority dateOct 19, 2016
Publication dateAug 23, 2022
Grant dateAug 23, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Beads with functionalized material applied to them are exposed to an acoustic field to trap or pass the beads. The beads may include or be free of ferro magnetic material. The beads may be biocompatible or biodegradable for a host. The size of the beads may vary over a range, and/or be heterogenous or homogenous. The composition of the beads may include high, neutral or low acoustic contrast material. The chemistry of the functionalized material may be compatible with existing processes.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for separating material in a fluid, comprising: applying a functionalized material to a plurality of non-magnetic biodegradable agarose beads that are acoustically responsive; in the fluid, exposing the beads to biomaterial with an affinity for the functionalized material to permit the biomaterial to bind to the beads, wherein the biomaterial is T cells; and exposing the beads in the fluid to an acoustic field and trapping the beads in the acoustic field. 2. The method of claim 1 , wherein the functionalized material is a streptavidin conjugate or a biotin conjugate. 3. The method of claim 1 , wherein the functionalized material is composed with an affinity for one or more of CD3, CD4 or CD8 receptors. 4. The method of claim 1 , wherein the functionalized material includes affine molecules that are one or more of antibodies, aptamers or oligonucleotides. 5. The method of claim 1 , wherein the functionalized material comprises a ligand. 6. The method of claim 1 , further comprising reversing a binding between the biomaterial and the beads. 7. The method of claim 1 , further comprising: a first biomaterial and a distinct second biomaterial included in the biomaterial; isolating the first biomaterial and isolating the second biomaterial; and combining the first biomaterial and the second biomaterial in a predetermined ratio. 8. The method of claim 1 , further comprising: targeted material and other material included in the biomaterial; and providing beads with an affinity for the targeted material to the fluid. 9. The method of claim 8 , further comprising increasing a density of the fluid to modify an acoustic contrast between the T cells and the fluid. 10. The method of claim 1 , wherein the plurality of beads include at least two different sizes of beads, each size being configured with an affinity for a different type of biomaterial. 11. A method for separating material in a fluid, comprising: generating an acoustic standing wave in a chamber suitable for housing a fluid; providing non-magnetic bead-biomaterial complexes to the chamber, wherein the beads are acoustically responsive non-magnetic biodegradable agarose beads, the biomaterial is T cells and the T cells are bound to the beads via a functionalized material with an affinity for the T cells; and in the fluid, trapping the non-magnetic bead-biomaterial complexes in the acoustic standing wave. 12. The method of claim 11 , wherein the acoustic standing wave is a multidimensional acoustic standing wave. 13. The method of claim 11 , further comprising binding the biomaterial to the non-magnetic beads to form the bead-biomaterial complexes prior to being provided to the chamber. 14. The method of claim 11 , further comprising trapping greater than 90% of the non-magnetic bead-biomaterial complexes in the acoustic standing wave.

Assignees

Inventors

Classifications

  • the carrier being characterised by its particulate form · CPC title

  • Separating microorganisms from their culture media · CPC title

  • C12M47/02Primary

    Separating microorganisms from the culture medium; Concentration of biomass (separating microorganisms from their culture media C12N1/02) · CPC title

  • Extraction; Separation; Purification · CPC title

  • Separation or concentration of fermentation products (bioreactors combined with means for distillation or extraction of liquid fuel C12M43/02) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11420136B2 cover?
Beads with functionalized material applied to them are exposed to an acoustic field to trap or pass the beads. The beads may include or be free of ferro magnetic material. The beads may be biocompatible or biodegradable for a host. The size of the beads may vary over a range, and/or be heterogenous or homogenous. The composition of the beads may include high, neutral or low acoustic contrast ma…
Who is the assignee on this patent?
Flodesign Sonics Inc
What technology area does this patent fall under?
Primary CPC classification C12M47/02. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).